<PAGE> 1
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
CLINICOR, INC.
- --------------------------------------------------------------------------------
(Name of Issuer)
COMMON STOCK, PAR VALUE $.001 PER SHARE
- --------------------------------------------------------------------------------
(Title of Class of Securities)
18726M106
- --------------------------------------------------------------------------------
(CUSIP Number)
The information required in the remainder of this cover page shall not
be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange
Act of 1934 ("Act") or otherwise subject to the liabilities of that section of
the Act but shall be subject to all other provisions of the Act.
CUSIP No. 18726M106
- --------------------------------------------------------------------------------
1. Name of Reporting Person and I.R.S. Identification Number
Sirrom Capital Corporation -- Taxpayer I.D. No. 62-1583116
- --------------------------------------------------------------------------------
2. Check the Appropriate Row if a Member of a Group
a. N/A
b. N/A
- --------------------------------------------------------------------------------
3. SEC Use Only
- --------------------------------------------------------------------------------
4. Citizenship or Place of Organization
Tennessee
- --------------------------------------------------------------------------------
Number of Shares Beneficially Owned by Each Reporting Person With:
5. Sole Voting Power 1,666,667 shares of Common Stock, receivable
upon conversion of Class B Convertible
Preferred Stock, without par value
6. Shared Voting Power N/A
7. Sole Dispositive Power 1,666,667 shares of Common Stock, receivable
upon conversion of Class B Convertible
Preferred Stock, without par value
<PAGE> 2
8. Shared Dispositive Power N/A
- --------------------------------------------------------------------------------
9. Aggregate Amount Beneficially Owned by Each Reporting Person
1,666,667 shares of Common Stock, receivable upon conversion of Class B
Convertible Preferred Stock, without par value
- --------------------------------------------------------------------------------
10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares
N/A
- --------------------------------------------------------------------------------
11. Percent of Class Represented by Amount in Row (9)
20.15% of Common Stock
- --------------------------------------------------------------------------------
12. Type of Reporting Person
IV
- --------------------------------------------------------------------------------
<PAGE> 3
ITEM 1(A). NAME OF ISSUER:
Clinicor, Inc.
ITEM 1(B). ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES:
1717 West Sixth Street, Suite 400
Austin, Texas 78703
ITEM 2(A). NAME OF PERSON FILING:
Sirrom Capital Corporation
ITEM 2(B). ADDRESS OF PRINCIPAL BUSINESS OFFICE:
500 Church Street, Suite 200
Nashville, Tennessee 37219
ITEM 2(C). CITIZENSHIP/STATE OF ORGANIZATION:
Tennessee
ITEM 2(D). TITLE OF CLASS OF SECURITIES:
Common Stock, par value $.001 per share
ITEM 2(E). CUSIP NUMBER:
18726M106
ITEM 3. FILING PURSUANT TO RULE 13D-1(B):
This statement is filed pursuant to Rule 13d-1(b). The person
filing is an Investment Company registered under section 8 of
the Investment Company Act.
ITEM 4. OWNERSHIP:
(a) Amount Beneficially Owned: 1,666,667 shares of
Common Stock, receivable upon conversion of Class
B Convertible Preferred Stock, without par value
(b) Percent of Class: 20.15% of Common Stock
(c) Number of shares as to which such person has:
(i) sole power to vote or direct the vote:
1,666,667, only upon conversion
(ii) shared power to vote or to direct the vote:
N/A
(iii) sole power to dispose or to direct the
disposition of: 1,666,667, only upon
conversion
(iv) shared power to dispose or to direct the
disposition of: N/A
ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS:
N/A
2
<PAGE> 4
ITEM 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER
PERSON:
N/A
ITEM 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH
ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING
COMPANY:
N/A.
ITEM 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP:
N/A.
ITEM 9. NOTICE OF DISSOLUTION OF GROUP:
N/A.
ITEM 10. CERTIFICATION:
By signing below I certify that, to the best of my knowledge and
belief, the securities referred to above were acquired in the ordinary course of
business and were not acquired for the purpose of and do not have the effect of
changing or influencing the control of the issuer of such securities and were
not acquired in connection with or as a participant in any transaction having
such purposes or effect.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this Schedule 13G is true, complete,
and correct.
Dated: December 10, 1997 SIRROM CAPITAL CORPORATION
By: /s/ Carl W. Stratton
-----------------------------
Carl W. Stratton, Chief Financial Officer
3
